Literature DB >> 25361944

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.

Youshan Zhao1, Dong Wu1, Chengming Fei1, Juan Guo1, Shuncheng Gu1, Yang Zhu1, Feng Xu1, Zheng Zhang1, Lingyun Wu1, Xiao Li1, Chunkang Chang2.   

Abstract

Although it has been reported that mesenchymal stromal cells are unable to provide sufficient hematopoietic support in myelodysplastic syndrome, the underlying mechanisms remain elusive. In this study, we found that mesenchymal stromal cells from patients with myelodysplastic syndrome displayed a significant increase in senescence, as evidenced by their decreased proliferative capacity, flattened morphology and increased expression of SA-β-gal and p21. Senescent mesenchymal stromal cells from patients had decreased differentiation potential and decreased stem cell support capacity. Gene knockdown of Dicer1, which was down-regulated in mesenchymal stromal cells from patients, induced senescence. The differentiation and stem cell-supporting capacities were significantly inhibited by Dicer1 knockdown. Overexpression of Dicer1 in mesenchymal stromal cells from patients reversed cellular senescence and enhanced stem cell properties. Furthermore, we identified reduced expression in the microRNA-17 family (miR-17-5p, miR-20a/b, miR-106a/b and miR-93) as a potential factor responsible for increased p21 expression, a key senescence mediator, in Dicer1 knockdown cells. Moreover, we found that miR-93 and miR-20a expression levels were significantly reduced in mesenchymal stromal cells from patients and miR-93/miR-20a gain of function resulted in a decrease of cellular senescence. Collectively, the results of our study show that mesenchymal stromal cells from patients with myelodysplastic syndrome are prone to senescence and that Dicer1 down-regulation promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells. Dicer1 down-regulation seems to contribute to the insufficient hematopoietic support capacities of mesenchymal stromal cells from patients with myelodysplastic syndrome. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361944      PMCID: PMC4803146          DOI: 10.3324/haematol.2014.109769

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

1.  Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells.

Authors:  Karin Stenderup; Jeannette Justesen; Christian Clausen; Moustapha Kassem
Journal:  Bone       Date:  2003-12       Impact factor: 4.398

2.  MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.

Authors:  Johan H Gibcus; Bart-Jan Kroesen; Roelof Koster; Nancy Halsema; Debora de Jong; Steven de Jong; Sibrand Poppema; Joost Kluiver; Arjan Diepstra; Anke van den Berg
Journal:  J Pathol       Date:  2011-09-26       Impact factor: 7.996

3.  Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence.

Authors:  Jiaqiang Ren; David F Stroncek; Yingdong Zhao; Ping Jin; Luciano Castiello; Sara Civini; Huan Wang; Ji Feng; Katherine Tran; Sergei A Kuznetsov; Pamela G Robey; Marianna Sabatino
Journal:  Stem Cell Res       Date:  2013-07-27       Impact factor: 2.020

4.  MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.

Authors:  Jie Gao; Tongtao Yang; Jianwei Han; Kang Yan; Xiuchun Qiu; Yong Zhou; Qingyu Fan; Baoan Ma
Journal:  J Cell Biochem       Date:  2011-07       Impact factor: 4.429

5.  Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients.

Authors:  Carlos Santamaría; Sandra Muntión; Beatriz Rosón; Belén Blanco; Olga López-Villar; Soraya Carrancio; Fermín M Sánchez-Guijo; María Díez-Campelo; Stela Alvarez-Fernández; María E Sarasquete; Javier de las Rivas; Marcos González; Jesús F San Miguel; María Consuelo Del Cañizo
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

6.  Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.

Authors:  Zhi-Gang Zhao; Wen Xu; Hai-Peng Yu; Bing-Ling Fang; Shu-Hong Wu; Fang Li; Wei-Min Li; Qiu-Bai Li; Zhi-Chao Chen; Ping Zou
Journal:  Cancer Lett       Date:  2011-10-15       Impact factor: 8.679

7.  Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells.

Authors:  Carmen Mariana Aanei; Florin Zugun Eloae; Pascale Flandrin-Gresta; Emmanuelle Tavernier; Eugen Carasevici; Denis Guyotat; Lydia Campos
Journal:  Exp Cell Res       Date:  2011-08-16       Impact factor: 3.905

Review 8.  Epigenetics of myelodysplastic syndromes.

Authors:  R Itzykson; P Fenaux
Journal:  Leukemia       Date:  2013-11-19       Impact factor: 11.528

9.  The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.

Authors:  Zhigang Zhao; Zhenling Wang; Qiubai Li; Weiming Li; Yong You; Ping Zou
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.

Authors:  Young-Kook Kim; Jieun Yu; Tae Su Han; Seong-Yeon Park; Bumjin Namkoong; Dong Hyuk Kim; Keun Hur; Moon-Won Yoo; Hyuk-Joon Lee; Han-Kwang Yang; V Narry Kim
Journal:  Nucleic Acids Res       Date:  2009-01-19       Impact factor: 16.971

View more
  20 in total

1.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

2.  Premature exhaustion of mesenchymal stromal cells from myelodysplastic syndrome patients.

Authors:  Yanbin Pang; Chengxin Deng; Suxia Geng; Jianyu Weng; Peilong Lai; Pengjun Liao; Lingji Zeng; Zesheng Lu; Jing Zhang; Xin Du
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

3.  Gene-expression and in vitro function of mesenchymal stromal cells are affected in juvenile myelomonocytic leukemia.

Authors:  Friso G J Calkoen; Carly Vervat; Else Eising; Lisanne S Vijfhuizen; Peter-Bram A C 't Hoen; Marry M van den Heuvel-Eibrink; R Maarten Egeler; Maarten J D van Tol; Lynne M Ball
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

4.  Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.

Authors:  Chengming Fei; Juan Guo; Youshan Zhao; Shucheng Gu; Sida Zhao; Xiao Li; Chunkang Chang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

5.  Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.

Authors:  Yuu Saitoh; Tomohiro Umezu; Satoshi Imanishi; Michiyo Asano; Seiichiro Yoshizawa; Seiichiro Katagiri; Tamiko Suguro; Hiroaki Fujimoto; Daigo Akahane; Chiaki Kobayashi-Kawana; Junko H Ohyashiki; Kazuma Ohyashiki
Journal:  Oncol Lett       Date:  2020-01-09       Impact factor: 2.967

Review 6.  Chronic immune response dysregulation in MDS pathogenesis.

Authors:  Laura Barreyro; Timothy M Chlon; Daniel T Starczynowski
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

Review 7.  Senescent Mesenchymal Stem Cells in Myelodysplastic Syndrome: Functional Alterations, Molecular Mechanisms, and Therapeutic Strategies.

Authors:  Xiaofang Chen; Ningyu Li; Jianyu Weng; Xin Du
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 8.  Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic.

Authors:  Eugenia Flores-Figueroa; Dita Gratzinger
Journal:  Int J Mol Sci       Date:  2016-04-13       Impact factor: 5.923

9.  Identity, proliferation capacity, genomic stability and novel senescence markers of mesenchymal stem cells isolated from low volume of human bone marrow.

Authors:  Gabrielis Kundrotas; Evelina Gasperskaja; Grazina Slapsyte; Zivile Gudleviciene; Jan Krasko; Ausra Stumbryte; Regina Liudkeviciene
Journal:  Oncotarget       Date:  2016-03-08

10.  Cytotoxic Therapy-Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms.

Authors:  Angela Stoddart; Jianghong Wang; Anthony A Fernald; Elizabeth M Davis; Camille R Johnson; Chunmei Hu; Jason X Cheng; Megan E McNerney; Michelle M Le Beau
Journal:  Blood Cancer Discov       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.